Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production

✍ Scribed by K. Shimada; T. Murayama; M. Yokode; T. Kita; M. Fujita; C. Kishimoto

• Book ID: 116800498
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 418 KB
• Volume: 21
• Category: Article
• ISSN: 0939-4753
• DOI: 10.1016/j.numecd.2009.12.016